RCAG
SILK

Rehmann Capital Advisory Group’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Rehmann Capital Advisory Group’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,472
Closed -$284K – 533
2020
Q4 		$284K Buy
+2,472
New +$153K 0.03% 385

Other funds holding SILK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Rehmann Capital Advisory Group's SILK Position: Q1 2021 in Review

Rehmann Capital Advisory Group sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q1 2021, closing a stake of 2,472 shares — an estimated $284K sold.

Rehmann Capital Advisory Group first reported a position in SILK in Q4 2020 and held it in 1 quarter. The position peaked at $284K in Q4 2020. 172 funds tracked by Wall St. Rank hold SILK as of Q1 2021.

  • Rehmann Capital Advisory Group reported no remaining Silk Road Medical, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Rehmann Capital Advisory Group sold 2,472 Silk Road Medical, Inc. Common Stock shares in Q1 2021, an estimated $284K.
  • Rehmann Capital Advisory Group first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
  • Rehmann Capital Advisory Group's Silk Road Medical, Inc. Common Stock position peaked at $284K in Q4 2020.
  • 172 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q1 2021.

Based on Rehmann Capital Advisory Group's 13F filing for Q1 2021, filed 26 May 2021.